The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Sarcolemma-localized nNOS is required to maintain activity after mild exercise
Open accessAbstract
Many neuromuscular conditions are characterized by an exaggerated exercise-induced fatigue response that is disproportionate to activity level. This fatigue is not necessarily correlated with greater central or peripheral fatigue in patients, and some patients experience severe fatigue without any demonstrable somatic disease. Except in myopathies that are due to specific metabolic defects, the mechanism underlying this type of fatigue remains unknown. With no treatment available, this form of inactivity is a major determinant of disability. Here we show, using mouse models, that this exaggerated fatigue response is distinct from a loss in specific force production by muscle, and that sarcolemma-localized signalling by neuronal nitric oxide synthase (nNOS) in skeletal muscle is required to maintain activity after mild exercise. We show that nNOS-null mice do not have muscle pathology and have no loss of muscle-specific force after exercise but do display this exaggerated fatigue response to mild exercise. In mouse models of nNOS mislocalization from the sarcolemma, prolonged inactivity was only relieved by pharmacologically enhancing the cGMP signal that results from muscle nNOS activation during the nitric oxide signalling response to mild exercise. Our findings suggest that the mechanism underlying the exaggerated fatigue response to mild exercise is a lack of contraction-induced signalling from sarcolemma-localized nNOS, which decreases cGMP-mediated vasomodulation in the vessels that supply active muscle after mild exercise. Sarcolemmal nNOS staining was decreased in patient biopsies from a large number of distinct myopathies, suggesting a common mechanism of fatigue. Our results suggest that patients with an exaggerated fatigue response to mild exercise would show clinical improvement in response to treatment strategies aimed at improving exercise-induced signalling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Membrane organization of the dystrophin-glycoprotein complex
Ervasti, J. M., & Campbell, K. P. (1991) · Cell · doi:10.1016/0092-8674(91)90035-w · Cited by 1,329
Self-citationPhysiology of Nitric Oxide in Skeletal Muscle
Stamler, J. S., & Meissner, G. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.209 · Cited by 1,080
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Takimoto, E., Champion, H. C., Li, M., Belardi, D., Ren, S., Rodriguez, E. R., Bedja, D., Gabrielson, K. L., Wang, Y., & Kass, D. A. (2005) · Nature Medicine · doi:10.1038/nm1175 · Cited by 903
Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy
Harper, S. Q., Hauser, M. A., DelloRusso, C., Duan, D., Crawford, R. W., Phelps, S. F., Harper, H. A., Robinson, A. S., Engelhardt, J. F., Brooks, S. V., et al. (2002) · Nature Medicine · doi:10.1038/nm0302-253 · Cited by 579
Self-citationWilliamson, R. A., Henry, M. D., Daniels, K. J., Hrstka, R. F., Lee, J. C., Sunada, Y., Ibraghimov-Beskrovnaya, O., & Campbell, K. P. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.6.831 · Cited by 541
Self-citationA nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice
Wehling, M., Spencer, M. J., & Tidball, J. G. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105110 · Cited by 530
Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man
WALKER, D. K. (1999) · Xenobiotica · doi:10.1080/004982599238687 · Cited by 401
Thomas, G. D., Sander, M., Lau, K. S., Huang, P. L., Stull, J. T., & Victor, R. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.15090 · Cited by 376
Long‐term individual housing in C57BL/6J and DBA/2 mice: assessment of behavioral consequences
Võikar, V., Polus, A., Vasar, E., & Rauvala, H. (2005) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2004.00106.x · Cited by 359
Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice
Duclos, F., Straub, V., Moore, S. A., Venzke, D. P., Hrstka, R. F., Crosbie, R. H., Durbeej, M., Lebakken, C. S., Ettinger, A. J., van der Meulen, J., et al. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.6.1461 · Cited by 356
Self-citationMouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1
Miki, T., Suzuki, M., Shibasaki, T., Uemura, H., Sato, T., Yamaguchi, K., Koseki, H., Iwanaga, T., Nakaya, H., & Seino, S. (2002) · Nature Medicine · doi:10.1038/nm0502-466 · Cited by 347
Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies
Grady, R. M., Grange, R. W., Lau, K. S., Maimone, M. M., Nichol, M. C., Stull, J. T., & Sanes, J. R. (1999) · Nature Cell Biology · doi:10.1038/12034 · Cited by 314
Clinical neurophysiology of fatigue
Zwarts, M. J., Bleijenberg, G., & van Engelen, B. G. M. (2008) · Clinical Neurophysiology · doi:10.1016/j.clinph.2007.09.126 · Cited by 248
Phosphodiesterase Type 5: Expanding Roles in Cardiovascular Regulation
Kass, D. A., Champion, H. C., & Beavo, J. A. (2007) · Circulation Research · doi:10.1161/circresaha.107.162511 · Cited by 217
Durbeej, M., Cohn, R. D., Hrstka, R. F., Moore, S. A., Allamand, V., Davidson, B. L., Williamson, R. A., & Campbell, K. P. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80410-4 · Cited by 209
Self-citationJohnson, J. E., Wold, B. J., & Hauschka, S. D. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.8.3393 · Cited by 207
NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS
Suzuki, N., Motohashi, N., Uezumi, A., Fukada, S.-I., Yoshimura, T., Itoyama, Y., Aoki, M., Miyagoe-Suzuki, Y., & Takeda, S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30654 · Cited by 188
Kameya, S., Miyagoe, Y., Nonaka, I., Ikemoto, T., Endo, M., Hanaoka, K., Nabeshima, Y.-I., & Takeda, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2193 · Cited by 184
Roberds, S. L., Anderson, R. D., Ibraghimov‐Beskrovnaya, O., & Campbell, K. P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80440-2 · Cited by 175
Self-citationMembrane Targeting and Stabilization of Sarcospan Is Mediated by the Sarcoglycan Subcomplex
Crosbie, R. H., Lebakken, C. S., Holt, K. H., Venzke, D. P., Straub, V. W., Lee, J. C., Grady, R. M., Chamberlain, J. S., Sanes, J. R., & Campbell, K. P. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.1.153 · Cited by 174
Self-citationMolecular and cell biology of the sarcoglycan complex
Ozawa, E., Mizuno, Y., Hagiwara, Y., Sasaoka, T., & Yoshida, M. (2005) · Muscle & Nerve · doi:10.1002/mus.20349 · Cited by 160
Straub, V. W., Ettinger, A. J., Durbeej, M., Venzke, D. P., Cutshall, S., Sanes, J. R., & Campbell, K. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27989 · Cited by 154
Self-citationThe Microcirculation and Inflammation: Site of Action for Glucocorticoids
Perretti, M., & Ahluwalia, A. (2000) · Microcirculation · doi:10.1111/j.1549-8719.2000.tb00117.x · Cited by 150
The Clinical Pharmacokinetics of Phosphodiesterase‐5 Inhibitors for Erectile Dysfunction
Gupta, M., Kovar, A., & Meibohm, B. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005276847 · Cited by 150
Thomas, G. D., Shaul, P. W., Yuhanna, I. S., Froehner, S. C., & Adams, M. E. (2003) · Circulation Research · doi:10.1161/01.res.0000061570.83105.52 · Cited by 149
Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging
Marden, F. A., Connolly, A. M., Siegel, M. J., & Rubin, D. A. (2004) · Skeletal Radiology · doi:10.1007/s00256-004-0825-3 · Cited by 145
Asai, A., Sahani, N., Kaneki, M., Ouchi, Y., Martyn, J. A. J., & Yasuhara, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000806 · Cited by 140
Neuronal Nitric Oxide Synthase Regulates Basal Microvascular Tone in Humans In Vivo
Seddon, M. D., Chowienczyk, P. J., Brett, S. E., Casadei, B., & Shah, A. M. (2008) · Circulation · doi:10.1161/circulationaha.107.744540 · Cited by 129
mdx muscle pathology is independent of nNOS perturbation
Crosbie, R. H., Straub, V., Yun, H. Y., Lee, J. C., Rafael, J. A., Chamberlain, J. S., Dawson, V. L., Dawson, T. M., & Campbell, K. P. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.5.823 · Cited by 128
Self-citationDissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex
Judge, L. M., Haraguchiln, M., & Chamberlain, J. S. (2006) · Journal of Cell Science · doi:10.1242/jcs.02857 · Cited by 128
Self-citationThe development of a model of fatigue in neuromuscular disorders: A longitudinal study
Kalkman, J. S., Schillings, M. L., Zwarts, M. J., van Engelen, B. G. M., & Bleijenberg, G. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2006.11.014 · Cited by 127
Experienced and physiological fatigue in neuromuscular disorders
Schillings, M. L., Kalkman, J. S., Janssen, H., van Engelen, B. G. M., Bleijenberg, G., & Zwarts, M. J. (2006) · Clinical Neurophysiology · doi:10.1016/j.clinph.2006.10.018 · Cited by 124
Archer, J. D., Vargas, C., & Anderson, J. E. (2006) · The FASEB Journal · doi:10.1096/fj.05-4821fje · Cited by 116
Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex
Cohn, R. D., Durbeej, M., Moore, S. A., Coral‐Vázquez, R. M., Prouty, S. J., & Campbell, K. P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11642 · Cited by 113
Self-citationSt-Pierre, S., Chakkalakal, J. V., Kolodziejczyk, S. M., Knudson, J., Jasmin, B. J., & Megeney, L. A. (2004) · The FASEB Journal · doi:10.1096/fj.04-1859fje · Cited by 112
Contractile properties of diaphragm muscle segments from old mdx and old transgenic mdx mice
Lynch, G. S., Rafael, J. A., Hinkle, R. T., Cole, N. M., Chamberlain, J. S., & Faulkner, J. A. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.272.6.c2063 · Cited by 107
Self-citationRegulated tissue- and cell-specific expression of the human renin gene in transgenic mice.
Sigmund, C. D., Jones, C. A., Kane, C. M., Wu, C., Lang, J., & Gross, K. W. (1992) · Circulation Research · doi:10.1161/01.res.70.5.1070 · Cited by 104
Hougee, S., Hartog, A., Sanders, A., Graus, Y., Hoijer, M. A., Garssen, J., van den Berg, W. B., van Beuningen, H. M., & Smit, H. F. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.11.061 · Cited by 102
Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide
Eu, J. P., Hare, J. M., Hess, D. T., Skaf, M. W., Sun, J., Cardenas-Navina, I., Sun, Q.-A., Dewhirst, M. W., Meissner, G., & Stamler, J. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2433468100 · Cited by 100
Duchenne muscular dystrophy: Focus on pharmaceutical and nutritional interventions
Radley‐Crabb, H. G., Luca, A. D., Lynch, G. S., & Grounds, M. D. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.09.009 · Cited by 93
Sarcospan-Deficient Mice Maintain Normal Muscle Function
Lebakken, C. S., Venzke, D. P., Hrstka, R. F., Consolino, C. M., Faulkner, J. A., Williamson, R. A., & Campbell, K. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1669-1677.2000 · Cited by 82
Self-citationAnderson, J. E., Weber, M., & Vargas, C. (2000) · Cell Transplantation · doi:10.1177/096368970000900411 · Cited by 81
Muscular Dystrophy in mdx Mice Despite Lack of Neuronal Nitric Oxide Synthase
Chao, D. S., Silvagno, F., & Bredt, D. S. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71020784.x · Cited by 76
Kinugawa, S., Wang, Z., Kaminski, P. M., Wolin, M. S., Edwards, J. G., Kaley, G., & Hintze, T. H. (2005) · Circulation · doi:10.1161/01.cir.0000159261.11520.63 · Cited by 64
Fadel, P. J., Zhao, W., & Thomas, G. D. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.038828 · Cited by 63
Muscle Fatigue Increases the Probability of Developing Hyperalgesia in Mice
Yokoyama, T., Lisi, T. L., Moore, S. A., & Sluka, K. A. (2007) · Journal of Pain · doi:10.1016/j.jpain.2007.05.008 · Cited by 59
Self-citationCyclic nucleotide phosphodiesterase isozymes expressed in mouse skeletal muscle
Bloom, T. J. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-149 · Cited by 57
Nitric Oxide in Skeletal Muscle: Inhibition of Nitric Oxide Synthase Inhibits Walking Speed in Rats
Wang, M.-X., Murrell, D. F., Szabó, C., Warren, R. F., Sarris, M., & Murrell, G. A. C. (2001) · Nitric Oxide · doi:10.1006/niox.2001.0348 · Cited by 51
Anderson, J. E., & Vargas, C. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(03)00029-4 · Cited by 43
Exercise therapy in patients with myopathy
Phillips, B. A., & Mastaglia, F. L. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200010000-00007 · Cited by 43
Elevation of Blood Glucose Following Anaesthetic Treatment in C57Bl/6 Mice
Pomplun, D., Möhlig, M., Spranger, J., Pfeiffer, A. F. H., & Ristow, M. (2004) · Hormone and Metabolic Research · doi:10.1055/s-2004-814104 · Cited by 42
-Sarcoglycan compensates for lack of -sarcoglycan in a mouse model of limb-girdle muscular dystrophy
Imamura, M., Mochizuki, Y., Engvall, E., & Takeda, S. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi072 · Cited by 38
Consolino, C. M., Duclos, F. J., Lee, J., Williamson, R. A., Campbell, K. P., & Brooks, S. V. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00311.2004 · Cited by 15
Self-citationMolecular-Targeted Therapy for Duchenne Muscular Dystrophy: Progress and Potential
Scimè, A., & Rudnicki, M. A. (2008) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256275 · Cited by 12
Bloom, T. J. (2005) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-085 · Cited by 12
Nitric oxide synthase is up-regulated in muscle fibers in muscular dystrophy
Punkt, K., Schering, S., Löffler, S., Minin, E. A., Samoilova, V. E., Hasselblatt, M., Paulus, W., Müller‐Werdan, U., Demus, U., Koehler, G., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.056 · Cited by 11
Cited by
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
Nelson, C. E., Hakim, C. H., Ousterout, D. G., Thakore, P. I., Moreb, E. A., Rivera, R. M. C., Madhavan, S., Pan, X., Ran, F. A., Yan, W. X., et al. (2016) · Science · doi:10.1126/science.aad5143 · Cited by 1,144
Cirak, S., Arechavala-Gomeza, V., Guglieri, M., Feng, L., Torelli, S., Anthony, K., Abbs, S., Garralda, M. E., Bourke, J., Wells, D. J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60756-3 · Cited by 878
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Francis, S. H., Blount, M. A., & Corbin, J. D. (2011) · Physiological Reviews · doi:10.1152/physrev.00030.2010 · Cited by 639
Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle
Bellinger, A. M., Reiken, S., Carlson, C., Mongillo, M., Liu, X., Rothman, L., Matecki, S., Lacampagne, A., & Marks, A. R. (2009) · Nature Medicine · doi:10.1038/nm.1916 · Cited by 531
Allen, D. G., Whitehead, N. P., & Froehner, S. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00007.2015 · Cited by 426
Metadata
- Authors
- Kobayashi, Y. M., Rader, E. P., Crawford, R. W., Iyengar, N. K., Thedens, D. R., Faulkner, J. A., Parikh, S. V., Weiss, R. M., Chamberlain, J. S., Moore, S. A., & Campbell, K. P.
- Venue
- Nature
- Published
- 2008-10-26
- Volume
- 456
- Issue
- 7221
- Pages
- 511-515
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2004740563
- Cited by
- 286
- References
- 57
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.